Abstract 1291
Case Summary
Patient. 46 years old. Female. Has been ill since 6 month. Has not another diseases. Family history free. Endoscopy has shown submucosal lesion with infiltrative tumor on the antrum. The size of the submocosal lesion was 2,5 x 3.0 cm. The overlying mucosa in the middle of the submucosal lesion was ulterated. The biopsies have taken from both sites. Histologic examination of infiltrative region revealed adenocarcinoma G3. Biopsies of submucosal lesion was negative. The physical examination and routine laboratory tests upon admission were unremarkable. The histopathologic examination after operation has revealed an adenocarcinoma G3 of stomach, that has been infiltrating into the muscular layer. In microscopic examination of submucosal lesion have been found a spindle cells neoplasm located in muscularis propria extending up to serosa. In immunohistochemical studing for desmin and CD-117 which confermed the diagnosis of gastrointestinal stromal tumor. The mitotic count was 6/50 HPF. Also, in the side with ulceration of GIST have been found cells of adenocarcinoma. The patient has been undergone distal subtotal gastrectomy and Billroth-II gastrojejunal anastomosis with D2 lymphadenectomy. The patient has not received imatinibas adjuvant therapy for the GIST, according to the international guidelines for GISTs risk stratification. The patient underwent regular clinical and radiological follow-up every 4 months after discharge. No evidence of tumor recurrence was found after 12 months of follow-up.
Editorial acknowledgement
Clinical trial identification
Resources from the same session
1310 - Upgrade of Low Grade Ductal Carcinoma in situ (DCIS): multimodality approach in a 10-year single institution study
Presenter: Ajung Chu
Session: Poster display - Cocktail
Resources:
Abstract
489 - Correlation between circulating tumor cells and the aromatase inhibitors therapy in postoperative patients with early breast cancer.
Presenter: Yumei Shi
Session: Poster display - Cocktail
Resources:
Abstract
838 - A Pilot Study of Single Pegfilgrastim Compared with Intermittent Every Other Days of 5 Shot-filgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) Chemotherapy (G-CSF 105 trial: NCT02685111)
Presenter: Jaeho Jeong
Session: Poster display - Cocktail
Resources:
Abstract
1337 - Painful scalp during chemotherapy induced hair loss is associated to permanent alopecia in breast cancer patients
Presenter: Nesrine Mejri
Session: Poster display - Cocktail
Resources:
Abstract
1445 - Breast cancer survival analysis in East Azerbaijan: five years cancer registry data in Iran
Presenter: Shima Pashaei
Session: Poster display - Cocktail
Resources:
Abstract
1457 - Is sarcopenia associated with increased toxicity of neoadjuvant/adjuvant chemotherapy for breast cancer?
Presenter: Ayako Ueno
Session: Poster display - Cocktail
Resources:
Abstract
759 - A Study on possibility of High Sensitivity C - reactive protein (hs-CRP) and Circulating Interluekin-6 (IL-6) as biomarker in Breast Cancer Patients
Presenter: Md Shah Jalalur Rahman Shahi
Session: Poster display - Cocktail
Resources:
Abstract
1447 - Correlation Between Expression of Topoisomerase II Alpha with Ki-67 and Tumor Size in Luminal B-Like Indonesian Breast Cancer Patients
Presenter: Helenia Putri
Session: Poster display - Cocktail
Resources:
Abstract
1175 - Association of Serum Vitamin D Level and Vitamin D Receptor Polymorphism (Apa 1) And Breast Cancer
Presenter: Suzy Gohar
Session: Poster display - Cocktail
Resources:
Abstract
911 - Prognostic Nomograms for Predicting Overall and Cancer-Specific Survival in Breast Cancer Patients Not Achieving Pathological Complete Response After Neoadjuvant Chemotherapy
Presenter: Jianguo Lai
Session: Poster display - Cocktail
Resources:
Abstract